State Street Corp Lexicon Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 2,607,574 shares of LXRX stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,607,574

Previous 2,718,248 4.07%

Holding current value

$1.9 Million

Previous $2.01 Million 40.38%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.29 - $0.96 $32,095 - $106,247	-110,674 Reduced 4.07%	2,607,574 $1.2 Million
Q4 2024 Feb 14, 2025	BUY	$0.65 - $2.08 $160,571 - $513,828	247,033 Added 10.0%	2,718,248 $2.01 Million
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $238,184 - $376,993	157,738 Added 6.82%	2,471,215 $3.88 Million
Q2 2024 Aug 14, 2024	BUY	$1.54 - $2.28 $501,989 - $743,204	325,967 Added 16.4%	2,313,477 $3.89 Million
Q1 2024 May 15, 2024	BUY	$1.3 - $3.58 $123,748 - $340,783	95,191 Added 5.03%	1,987,510 $4.77 Million
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $16,180 - $24,755	16,180 Added 0.86%	1,892,319 $2.9 Million
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $154,788 - $340,242	146,027 Added 8.44%	1,876,139 $2.04 Million
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $356,930 - $579,388	166,014 Added 10.61%	1,730,112 $3.96 Million
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $94,769 - $127,629	47,623 Added 3.14%	1,564,098 $3.8 Million
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $95,230 - $135,439	52,906 Added 3.61%	1,516,475 $2.9 Million
Q3 2022 Nov 15, 2022	BUY	$1.94 - $3.43 $216,441 - $382,678	111,568 Added 8.25%	1,463,569 $3.51 Million
Q2 2022 Aug 15, 2022	BUY	$1.31 - $2.69 $36,176 - $74,287	27,616 Added 2.09%	1,352,001 $2.52 Million
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $213,265 - $425,437	109,367 Added 9.0%	1,324,385 $2.77 Million
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $431,539 - $697,712	113,265 Added 10.28%	1,215,018 $4.79 Million
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $216,678 - $342,967	64,106 Added 6.18%	1,101,753 $5.3 Million
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $1.18 Million - $1.69 Million	287,262 Added 38.28%	1,037,647 $4.76 Million
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $75,178 - $198,080	21,791 Added 2.99%	750,385 $4.41 Million
Q4 2020 Feb 16, 2021	SELL	$1.05 - $3.67 $22,329 - $78,046	-21,266 Reduced 2.84%	728,594 $2.49 Million
Q3 2020 Nov 10, 2020	BUY	$1.44 - $2.1 $5,647 - $8,236	3,922 Added 0.53%	749,860 $1.08 Million
Q2 2020 Aug 14, 2020	SELL	$1.75 - $2.3 $141,538 - $186,021	-80,879 Reduced 9.78%	745,938 $1.49 Million
Q1 2020 May 11, 2020	BUY	$1.8 - $4.28 $1.49 Million - $3.54 Million	826,817 New	826,817 $1.61 Million

Others Institutions Holding LXRX

# of Institutions

135

Shares Held

196M

Call Options Held

310K

Put Options Held

77.3K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $138M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Lexicon Pharmaceuticals, Inc. Transaction History